You have not done so. We find that this gives us real problems in terms of understanding what is to be done or should be done.
The process by which we arrive at good standards is a matter of great importance to me.
It is my understanding that the FDA has been working to address shortages of medically necessary drugs.
This is a matter on which I have worked with the gentleman, my colleague Mr. Shimkus.
I have got some legislation to address that and I hope that we will be shortly addressing it here in this committee.
At the end of the day, American consumers and patients are facing 3 problems: 1) the drugs, they need to be available and affordable; 2) are...
I hope that we don't take the failure, for whatever reason, of this project to mean that all renewable energy projects are bad investments.
Do you have authority at FDA or at HHS to waive any of the requirements with regard to efficacy, good manufacturing practices, or safety, ye...
I have a bill that would require manufacturers to maintain records establishing where the drug and its raw materials were produced.
I believe that agency has documented that fact over the course of 3 years and two administrations, one of each, Republican and Democratic.
Mr. Chairman, thank you for your courtesy.